XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income $ 18,347 $ 64,347
Adjustment to reconcile net income to net cash flows from operating activities:    
Amortization and accretion of premiums, discounts and loan origination fees, net (3,627) (3,775)
Amortization of deferred financing costs 7,400 7,644
Decrease of accrued capitalized interest 613 548
Gain on sale of real estate owned, net (13,291) 0
Loss on sales of loans held for investment, net 0 1,626
Stock compensation expense 2,594 2,849
Increase (decrease) of allowance for credit losses, net (see Note 3) 47,174 (7,515)
Cash flows due to changes in operating assets and liabilities:    
Accounts receivable 50 30
Accrued interest receivable (2,260) (2,051)
Accrued expenses and other liabilities 757 (4,716)
Accrued interest payable 1,577 146
Payable to affiliates 5,430 167
Deferred fee income (302) (97)
Other assets 611 1,857
Net cash provided by operating activities 65,073 61,060
Cash flows from investing activities:    
Origination of loans held for investment (535,053) (631,408)
Advances on loans held for investment (58,558) (73,136)
Principal repayments of loans held for investment 414,118 282,583
Sale of real estate owned 73,913 0
Sales of loans held for investment 0 58,374
Net cash (used in) investing activities (105,580) (363,587)
Cash flows from financing activities:    
Payments on collateralized loan obligations (811,100) (36,373)
Proceeds from collateralized loan obligations 907,031 1,037,500
Payments on secured financing agreements (871,970) (868,083)
Proceeds from secured financing agreements 847,479 208,435
Proceeds from asset-specific financing arrangements 124,202 0
Payment of deferred financing costs (10,242) (8,119)
Proceeds from issuance of Series C Cumulative Redeemable Preferred Stock 0 201,250
Series B Preferred Stock redemption make-whole payment 0 (22,485)
Payment of Equity Issuance and Equity Distribution Agreement transaction costs 0 (6,360)
Net cash provided by financing activities 136,251 223,429
Net change in cash, cash equivalents, and restricted cash 95,744 (79,098)
Cash, cash equivalents and restricted cash at beginning of period 261,039 319,669
Cash, cash equivalents and restricted cash at end of period 356,783 240,571
Supplemental disclosure of cash flow information:    
Interest paid 41,604 34,526
Taxes paid 125 973
Supplemental disclosure of non-cash investing and financing activities:    
Collateralized loan obligation proceeds held at trustee 130,704 0
Dividends payable 18,726 [1] 15,500
Principal repayments of loans held for investment held by servicer/trustee, net 259,595 55,872
Accrued Equity Issuance and Transaction Costs 0 506
Accrued deferred financing costs 388 587
Common Stock, Undefined Class    
Cash flows from financing activities:    
Dividends paid (42,853) (44,998)
Preferred Stock, Undefined Class    
Cash flows from financing activities:    
Dividends paid (6,296) (12,338)
Series B Preferred Stock    
Cash flows from financing activities:    
Series B Preferred Stock redemption at par value $ 0 $ (225,000)
[1] The Company’s consolidated Total Assets and Total Liabilities as of June 30, 2022 include assets and liabilities of variable interest entities (“VIEs”) of $3.2 billion and $2.6 billion, respectively. The Company’s consolidated Total Assets and Total Liabilities as of December 31, 2021 include assets and liabilities of VIEs of $3.2 billion and $2.6 billion, respectively. These assets can be used only to satisfy obligations of the VIEs, and creditors of the VIEs have recourse only to these assets, and not to TPG RE Finance Trust, Inc. See Note 5 to the Consolidated Financial Statements for details.